Review



mouse anti dok2 monoclonal antibody  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Santa Cruz Biotechnology mouse anti dok2 monoclonal antibody
    Serum <t>anti-DOK2</t> antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.
    Mouse Anti Dok2 Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 23 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+dok2+monoclonal+antibody/Dok-2+Antibody/pmc12456515-139-8-15
    Average 93 stars, based on 23 article reviews
    mouse anti dok2 monoclonal antibody - by Bioz Stars, 2026-11
    93/100 stars

    Images

    1) Product Images from "Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray"

    Article Title: Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray

    Journal: Hepatology Communications

    doi: 10.1097/HC9.0000000000000807

    Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.
    Figure Legend Snippet: Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Techniques Used: Comparison

    Related Articles

    Tissue:

    Article Title: Expression and significance of DOK2 in colorectal cancer
    Article Snippet: .. The tissue sections were incubated with a primary mouse anti-DOK2 monoclonal antibody (sc-17830; dilution 1:200; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) at 4°C overnight, and stained using the labeled streptavidinbiotin method. ..

    Article Title: Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray
    Article Snippet: .. The tissue sections were incubated with a primary mouse anti-DOK2 monoclonal antibody (sc-17830; dilution 1:25; Santa Cruz Biotechnology Inc.) or a CD68 mouse monoclonal antibody (AT1379-1; Nichirei Bioscience Inc.) for 20 minutes at 25°C. ..

    Incubation:

    Article Title: Expression and significance of DOK2 in colorectal cancer
    Article Snippet: .. The tissue sections were incubated with a primary mouse anti-DOK2 monoclonal antibody (sc-17830; dilution 1:200; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) at 4°C overnight, and stained using the labeled streptavidinbiotin method. ..

    Article Title: Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray
    Article Snippet: .. The tissue sections were incubated with a primary mouse anti-DOK2 monoclonal antibody (sc-17830; dilution 1:25; Santa Cruz Biotechnology Inc.) or a CD68 mouse monoclonal antibody (AT1379-1; Nichirei Bioscience Inc.) for 20 minutes at 25°C. ..

    Staining:

    Article Title: Expression and significance of DOK2 in colorectal cancer
    Article Snippet: .. The tissue sections were incubated with a primary mouse anti-DOK2 monoclonal antibody (sc-17830; dilution 1:200; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) at 4°C overnight, and stained using the labeled streptavidinbiotin method. ..

    Labeling:

    Article Title: Expression and significance of DOK2 in colorectal cancer
    Article Snippet: .. The tissue sections were incubated with a primary mouse anti-DOK2 monoclonal antibody (sc-17830; dilution 1:200; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) at 4°C overnight, and stained using the labeled streptavidinbiotin method. ..



    Similar Products

    mouse anti dok2 monoclonal antibody  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology mouse anti dok2 monoclonal antibody
    Serum <t>anti-DOK2</t> antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.
    Mouse Anti Dok2 Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+dok2+monoclonal+antibody/Dok-2+Antibody/pmc12456515-139-8-15
    Average 93 stars, based on 1 article reviews
    mouse anti dok2 monoclonal antibody - by Bioz Stars, 2026-11
    93/100 stars
    		  Buy from Supplier
    primary mouse anti-dok2 monoclonal antibody  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology primary mouse anti-dok2 monoclonal antibody
    Immunostaining for <t>DOK2</t> in normal colorectal mucosa and colorectal cancer tissues. (A) Immunoreactivity to DOK2 in the normal colorectal mucosa, (B) DOK2 immunoreactivity in colorectal adenocarcinoma diagnosed as moderately-differentiated adenocarcinoma, and (C) negative immunostaining for DOK2 in colorectal adenocarcinoma diagnosed as poorly-differentiated adenocarcinoma (magnification, ×100). DOK2, docking protein 2.
    Primary Mouse Anti Dok2 Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+dok2+monoclonal+antibody/anti+dok2/pmc04246696-49-24-34
    Average 90 stars, based on 1 article reviews
    primary mouse anti-dok2 monoclonal antibody - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    mouse monoclonal anti dok2  (Cell Signaling Technology Inc)
    91
    Cell Signaling Technology Inc mouse monoclonal anti dok2
    Immunostaining for <t>DOK2</t> in normal colorectal mucosa and colorectal cancer tissues. (A) Immunoreactivity to DOK2 in the normal colorectal mucosa, (B) DOK2 immunoreactivity in colorectal adenocarcinoma diagnosed as moderately-differentiated adenocarcinoma, and (C) negative immunostaining for DOK2 in colorectal adenocarcinoma diagnosed as poorly-differentiated adenocarcinoma (magnification, ×100). DOK2, docking protein 2.
    Mouse Monoclonal Anti Dok2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+dok2+monoclonal+antibody/Phospho-p90RSK+(Ser380)+Rabbit+mAb/pm22089930-77-57-41
    Average 91 stars, based on 1 article reviews
    mouse monoclonal anti dok2 - by Bioz Stars, 2026-11
    91/100 stars
    		  Buy from Supplier
    mouse monoclonal anti dok2  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology mouse monoclonal anti dok2
    Immunostaining for <t>DOK2</t> in normal colorectal mucosa and colorectal cancer tissues. (A) Immunoreactivity to DOK2 in the normal colorectal mucosa, (B) DOK2 immunoreactivity in colorectal adenocarcinoma diagnosed as moderately-differentiated adenocarcinoma, and (C) negative immunostaining for DOK2 in colorectal adenocarcinoma diagnosed as poorly-differentiated adenocarcinoma (magnification, ×100). DOK2, docking protein 2.
    Mouse Monoclonal Anti Dok2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+dok2+monoclonal+antibody/Dok-2+Antibody/pm22089930-77-57-91
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti dok2 - by Bioz Stars, 2026-11
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Journal: Hepatology Communications

    Article Title: Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray

    doi: 10.1097/HC9.0000000000000807

    Figure Lengend Snippet: Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Article Snippet: The tissue sections were incubated with a primary mouse anti-DOK2 monoclonal antibody (sc-17830; dilution 1:25; Santa Cruz Biotechnology Inc.) or a CD68 mouse monoclonal antibody (AT1379-1; Nichirei Bioscience Inc.) for 20 minutes at 25°C.

    Techniques: Comparison

    Immunostaining for DOK2 in normal colorectal mucosa and colorectal cancer tissues. (A) Immunoreactivity to DOK2 in the normal colorectal mucosa, (B) DOK2 immunoreactivity in colorectal adenocarcinoma diagnosed as moderately-differentiated adenocarcinoma, and (C) negative immunostaining for DOK2 in colorectal adenocarcinoma diagnosed as poorly-differentiated adenocarcinoma (magnification, ×100). DOK2, docking protein 2.

    Journal: Oncology Letters

    Article Title: Expression and significance of DOK2 in colorectal cancer

    doi: 10.3892/ol.2014.2672

    Figure Lengend Snippet: Immunostaining for DOK2 in normal colorectal mucosa and colorectal cancer tissues. (A) Immunoreactivity to DOK2 in the normal colorectal mucosa, (B) DOK2 immunoreactivity in colorectal adenocarcinoma diagnosed as moderately-differentiated adenocarcinoma, and (C) negative immunostaining for DOK2 in colorectal adenocarcinoma diagnosed as poorly-differentiated adenocarcinoma (magnification, ×100). DOK2, docking protein 2.

    Article Snippet: Following blocking with 10% skimmed milk in Tris-buffered saline containing 0.1% Tween 20 (TBST; Boster Company), the blots were incubated overnight with the primary mouse anti-DOK2 monoclonal antibody (1:1,500; diluted in TBST/4% skimmed milk; Santa Cruz Biotechnology Inc.) at 4°C.

    Techniques: Immunostaining

    Western blotting to detect DOK2 protein expression. Six samples were selected, four DOK-2(+) cases and two DOK2(−) cases. DOK2, docking protein 2; P, poorly-differentiated adenocarcinoma; M, moderately-differentiated adenocarcinoma.

    Journal: Oncology Letters

    Article Title: Expression and significance of DOK2 in colorectal cancer

    doi: 10.3892/ol.2014.2672

    Figure Lengend Snippet: Western blotting to detect DOK2 protein expression. Six samples were selected, four DOK-2(+) cases and two DOK2(−) cases. DOK2, docking protein 2; P, poorly-differentiated adenocarcinoma; M, moderately-differentiated adenocarcinoma.

    Article Snippet: Following blocking with 10% skimmed milk in Tris-buffered saline containing 0.1% Tween 20 (TBST; Boster Company), the blots were incubated overnight with the primary mouse anti-DOK2 monoclonal antibody (1:1,500; diluted in TBST/4% skimmed milk; Santa Cruz Biotechnology Inc.) at 4°C.

    Techniques: Western Blot, Expressing

    Correlation between DOK2 expression and various clinicopathological parameters.

    Journal: Oncology Letters

    Article Title: Expression and significance of DOK2 in colorectal cancer

    doi: 10.3892/ol.2014.2672

    Figure Lengend Snippet: Correlation between DOK2 expression and various clinicopathological parameters.

    Article Snippet: Following blocking with 10% skimmed milk in Tris-buffered saline containing 0.1% Tween 20 (TBST; Boster Company), the blots were incubated overnight with the primary mouse anti-DOK2 monoclonal antibody (1:1,500; diluted in TBST/4% skimmed milk; Santa Cruz Biotechnology Inc.) at 4°C.

    Techniques: Expressing

    Kaplan-Meier curves for overall survival (OS) and relapse-free survival (RFS) according to DOK2 expression. (A) OS curve and (B) RFS curve according to DOK2 expression for all patients. Differences between the two groups were evaluated by log-rank test. Ordinate survival rate, abscissa time after surgery (years). DOK2, docking protein 2.

    Journal: Oncology Letters

    Article Title: Expression and significance of DOK2 in colorectal cancer

    doi: 10.3892/ol.2014.2672

    Figure Lengend Snippet: Kaplan-Meier curves for overall survival (OS) and relapse-free survival (RFS) according to DOK2 expression. (A) OS curve and (B) RFS curve according to DOK2 expression for all patients. Differences between the two groups were evaluated by log-rank test. Ordinate survival rate, abscissa time after surgery (years). DOK2, docking protein 2.

    Article Snippet: Following blocking with 10% skimmed milk in Tris-buffered saline containing 0.1% Tween 20 (TBST; Boster Company), the blots were incubated overnight with the primary mouse anti-DOK2 monoclonal antibody (1:1,500; diluted in TBST/4% skimmed milk; Santa Cruz Biotechnology Inc.) at 4°C.

    Techniques: Expressing